Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Neurocase|August 22, 2013
Unawareness of deficits in ischemic injury: role of the cingulate cortexS Palermo, D Leotta, M R Bongioanni, et al.Clinical Chemistry|May 1, 1997
Modified and improved anti-acetylcholine receptor (AchR) antibody assay: comparison of analytical and clinical performance with conventional anti-AChR antibody assayB Ferrero, G Aimo, R Pagni, et al.Journal of the Neurological Sciences|November 1, 1996
Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosisM R Bongioanni, L Durelli, B Ferrero, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune functionL Durelli, M R Bongioanni, R Cavallo, et al.Neurology|July 1, 1996
Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatmentL Durelli, M R Bongioanni, B Ferrero, et al.Neurology|March 1, 1994
Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosisL Durelli, M R Bongioanni, R Cavallo, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
Long term recombinant interferon alpha treatment in MS with special emphasis to side effectsL Durelli, M R Bongioanni, B Ferrero, et al.Journal of the Neurological Sciences|March 4, 1999
Autoimmune events during interferon beta-1b treatment for multiple sclerosisL Durelli, B Ferrero, A Oggero, et al.Pageof 1